279 related articles for article (PubMed ID: 3138113)
1. Purification of the human immunodeficiency virus type 1 enhancer and TAR binding proteins EBP-1 and UBP-1.
Wu FK; Garcia JA; Harrich D; Gaynor RB
EMBO J; 1988 Jul; 7(7):2117-30. PubMed ID: 3138113
[TBL] [Abstract][Full Text] [Related]
2. Human immunodeficiency virus type 1 LTR TATA and TAR region sequences required for transcriptional regulation.
Garcia JA; Harrich D; Soultanakis E; Wu F; Mitsuyasu R; Gaynor RB
EMBO J; 1989 Mar; 8(3):765-78. PubMed ID: 2721501
[TBL] [Abstract][Full Text] [Related]
3. Role of SP1-binding domains in in vivo transcriptional regulation of the human immunodeficiency virus type 1 long terminal repeat.
Harrich D; Garcia J; Wu F; Mitsuyasu R; Gonazalez J; Gaynor R
J Virol; 1989 Jun; 63(6):2585-91. PubMed ID: 2657100
[TBL] [Abstract][Full Text] [Related]
4. Distinct transcriptional pathways of TAR-dependent and TAR-independent human immunodeficiency virus type-1 transactivation by Tat.
Yang L; Morris GF; Lockyer JM; Lu M; Wang Z; Morris CB
Virology; 1997 Aug; 235(1):48-64. PubMed ID: 9300036
[TBL] [Abstract][Full Text] [Related]
5. NF-kappa B site-mediated negative regulation of the HIV-1 promoter by CCAAT/enhancer binding proteins in brain-derived cells.
Mondal D; Alam J; Prakash O
J Mol Neurosci; 1994-1995; 5(4):241-58. PubMed ID: 7577367
[TBL] [Abstract][Full Text] [Related]
6. PU.1 binding to ets motifs within the equine infectious anemia virus long terminal repeat (LTR) enhancer: regulation of LTR activity and virus replication in macrophages.
Hines R; Sorensen BR; Shea MA; Maury W
J Virol; 2004 Apr; 78(7):3407-18. PubMed ID: 15016863
[TBL] [Abstract][Full Text] [Related]
7. Alterations in binding characteristics of the human immunodeficiency virus enhancer factor.
Wu F; Garcia J; Mitsuyasu R; Gaynor R
J Virol; 1988 Jan; 62(1):218-25. PubMed ID: 3257103
[TBL] [Abstract][Full Text] [Related]
8. Transdominant mutants of I kappa B alpha block Tat-tumor necrosis factor synergistic activation of human immunodeficiency virus type 1 gene expression and virus multiplication.
Beauparlant P; Kwon H; Clarke M; Lin R; Sonenberg N; Wainberg M; Hiscott J
J Virol; 1996 Sep; 70(9):5777-85. PubMed ID: 8709193
[TBL] [Abstract][Full Text] [Related]
9. Differential role of long terminal repeat control elements for the regulation of basal and Tat-mediated transcription of the human immunodeficiency virus in stimulated and unstimulated primary human macrophages.
Moses AV; Ibanez C; Gaynor R; Ghazal P; Nelson JA
J Virol; 1994 Jan; 68(1):298-307. PubMed ID: 8254741
[TBL] [Abstract][Full Text] [Related]
10. Regulation of avian leukosis virus long terminal repeat-enhanced transcription by C/EBP-Rel interactions.
Bowers WJ; Baglia LA; Ruddel A
J Virol; 1996 May; 70(5):3051-9. PubMed ID: 8627783
[TBL] [Abstract][Full Text] [Related]
11. The VBP and a1/EBP leucine zipper factors bind overlapping subsets of avian retroviral long terminal repeat CCAAT/enhancer elements.
Smith CD; Baglia LA; Curristin SM; Ruddell A
J Virol; 1994 Oct; 68(10):6232-42. PubMed ID: 8083963
[TBL] [Abstract][Full Text] [Related]
12. Transcription factor PRDII-BF1 activates human immunodeficiency virus type 1 gene expression.
Seeler JS; Muchardt C; Suessle A; Gaynor RB
J Virol; 1994 Feb; 68(2):1002-9. PubMed ID: 8289330
[TBL] [Abstract][Full Text] [Related]
13. Repeated B motifs in the human immunodeficiency virus type I long terminal repeat enhancer region do not exhibit cooperative factor binding.
Gaynor RB; Kuwabara MD; Wu FK; Garcia JA; Harrich D; Briskin M; Wall R; Sigman DS
Proc Natl Acad Sci U S A; 1988 Dec; 85(24):9406-10. PubMed ID: 3200827
[TBL] [Abstract][Full Text] [Related]
14. T-cell activation leads to poor activation of the HIV-1 clade E long terminal repeat and weak association of nuclear factor-kappaB and NFAT with its enhancer region.
Lemieux AM; Paré ME; Audet B; Legault E; Lefort S; Boucher N; Landry S; van Opijnen T; Berkhout B; Naghavi MH; Tremblay MJ; Barbeau B
J Biol Chem; 2004 Dec; 279(51):52949-60. PubMed ID: 15466412
[TBL] [Abstract][Full Text] [Related]
15. Cloning and characterization of a novel cellular protein, TDP-43, that binds to human immunodeficiency virus type 1 TAR DNA sequence motifs.
Ou SH; Wu F; Harrich D; García-Martínez LF; Gaynor RB
J Virol; 1995 Jun; 69(6):3584-96. PubMed ID: 7745706
[TBL] [Abstract][Full Text] [Related]
16. An NF-kappaB site in the 5'-untranslated leader region of the human immunodeficiency virus type 1 enhances the viral expression in response to NF-kappaB-activating stimuli.
Mallardo M; Dragonetti E; Baldassarre F; Ambrosino C; Scala G; Quinto I
J Biol Chem; 1996 Aug; 271(34):20820-7. PubMed ID: 8702837
[TBL] [Abstract][Full Text] [Related]
17. Evolution of the human immunodeficiency virus type 1 long terminal repeat promoter by conversion of an NF-kappaB enhancer element into a GABP binding site.
Verhoef K; Sanders RW; Fontaine V; Kitajima S; Berkhout B
J Virol; 1999 Feb; 73(2):1331-40. PubMed ID: 9882338
[TBL] [Abstract][Full Text] [Related]
18. Putative metal finger structure of the human immunodeficiency virus type 1 enhancer binding protein HIV-EP1.
Maekawa T; Sakura H; Sudo T; Ishii S
J Biol Chem; 1989 Sep; 264(25):14591-3. PubMed ID: 2504707
[TBL] [Abstract][Full Text] [Related]
19. Regulation of HIV-1 long terminal repeats by interaction of C/EBP(NF-IL6) and NF-kappaB/Rel transcription factors.
Ruocco MR; Chen X; Ambrosino C; Dragonetti E; Liu W; Mallardo M; De Falco G; Palmieri C; Franzoso G; Quinto I; Venuta S; Scala G
J Biol Chem; 1996 Sep; 271(37):22479-86. PubMed ID: 8798413
[TBL] [Abstract][Full Text] [Related]
20. Interactions of cellular proteins involved in the transcriptional regulation of the human immunodeficiency virus.
Garcia JA; Wu FK; Mitsuyasu R; Gaynor RB
EMBO J; 1987 Dec; 6(12):3761-70. PubMed ID: 3428273
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
